Breast Cancer Clinical Trial
Researchers at Dana-Farber Cancer Institute target breast cancer clinical trial
Published in Women's Health Law Weekly, July 29th, 2007
Data detailed in "Aromatase inhibitor-associated arthralgia syndrome" have been presented. According to recent research published in the journal The Breast, "Aromatase inhibitors (AIs) are widely used as an adjuvant endocrine treatment in postmenopausal women with early-stage breast cancer. Clinical trials have assessed 5 years of AI therapy, either as an alternative to tamoxifen for primary adjuvant therapy of breast cancer, or after 5 years of adjuvant tamoxifen."
"Treatment of 2-3 years' duration after 2-3 years of tamoxifen has also been studied. AI therapy brings side effects related to estrogen deprivation, and this side effect profile differs in clinically...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- HIV/AIDS Prevention
Researchers from University of Medicine and Dentistry of New Jersey provide details of new studies and findings in the area of HIV/AIDS prevention - Menopause
Noven To Acquire Jds Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline - Women's Health
Breastfeeding, Childbirth and Parenting Experts Gather for La Leche League International 50th Anniversary Conference - Aging
Link between carbohydrate quality and vision loss is strengthened by new data - Anesthesia
School of Medicine, Department of Urology reports research in anesthesia - Angiogenesis
Research data from University of Kuopio, Institute of Clinical Medicine update understanding of angiogenesis - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
